subject: Periodontal Disease - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise [print this page] Periodontal Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Summary
The industry analysis specialists new report, Periodontal disease - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global periodontal disease market. The report identifies the key trends shaping and driving the global periodontal disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global periodontal disease sector.
The global periodontal disease market was valued at $1,248m in 2009 and is characterized by efficacious dental procedures such as scaling, root planing and surgery. The periodontal therapeutics market comprises Local Applied Antibodies (LAAs) and systemic applied antibodies. The influx of new drugs and the increase in the uptake of LAAs will the drive the market in the forecast period. The various phases of the developmental pipeline contain 19 molecules. Of these, only five are in Phase III and the rest are in the early stages of development. The pipeline consists of no new antibiotics. The combinations of the tetracylines are expected to improve the efficacy of the treatment. However, the drug is similar in nature to doxycyclines. The entry of cost effective drugs in the forecast period is expected to aid the market growth.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.
Scope
The scope of the report includes:
- Annualized global periodontal disease market revenues data from 2001 to 2009, forecast for seven years to 2016.
- Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include tetracycline antibiotics, osteoblast stimulators and anti-inflammatories, H+/K+ ATPase inhibitors; cell wall synthesis inhibitors.
- Analysis of the current and future market competition in the global periodontal disease market. The key market players covered are Kaken Pharmaceutical, Fibrocell Science, Inc., and Combinatorx, Inc.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future periodontal disease market.
